FDA Okays Drug to Curb Pancreatitis in Hypertriglyceridemia

The expanded indication makes olezarsen the first therapy approved to reduce the acute pancreatitis risk in adults with severe hypertriglyceridemia.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-okays-drug-curb-acute-pancreatitis-severe-2026a1000lhk?src=rss

Author :

Publish date : 2026-06-24 19:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

FDA Okays Drug to Curb Pancreatitis in Hypertriglyceridemia

Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk

Can Advanced MRI Personalize Radiation for Glioblastoma?

Related Posts

Obesity cases rising fastest in young adults

Long-Term CAR-T Results in Lymphoma Confirm Early Promise

ALS Testing Expected to Drive Sharp Rise in Clinic Visits

Midterm TAVR Data Turn Muddy: Will 10 Years Even Suffice for a Verdict?

Health Spending Projected to Hit Almost $9 Trillion in 2034

Few IVF Add-Ons Have Any Proven Benefits, Study Shows

Obesity cases rising fastest in young adults

Long-Term CAR-T Results in Lymphoma Confirm Early Promise

ALS Testing Expected to Drive Sharp Rise in Clinic Visits

Midterm TAVR Data Turn Muddy: Will 10 Years Even Suffice for a Verdict?

Health Spending Projected to Hit Almost $9 Trillion in 2034

Few IVF Add-Ons Have Any Proven Benefits, Study Shows

South African Civil Groups Warn of Dire Impact as U.S. Phases Out HIV Funding

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Categories

Archives